Drugs / MenBVac
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00197795 | Jan 2005 → Dec 2006 | meningococcal infection | Public Health England | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01565577 | Apr → Jun 2012 | — | University Hospital, Rouen | Completed | No outcome recorded |
| Phase 3 | NCT01621945 | Apr 2012 → Apr 2013 | meningococcal infection | University Hospital, Rouen | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01054053 | Apr 2009 → Oct 2010 | — | University Hospital, Rouen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MenBvac | “Norwegian meningococcal outer membrane vesicle vaccine MenBvac” PMID 16861642 ↗ Aug 2006 |
| Modality | Vaccine | “A phase II trial of the OMV vaccine, MenBvac” PMID 16861642 ↗ Aug 2006 |